Formation of a clinical profile of ambulatory patients with benign prostatic hyperplasia in Moscow
The objective. Formation of a clinical profile of patients with prostatic hyperplasia followed up in ambulatory settings in Moscow. Patients and methods. The study was conducted from January to April 2017. Questionnaires were filled in by 189 outpatients who were observed by urologists with the diagnosis of benign prostatic hyperplasia (BPH). In formation of the clinical profile we used sociodemographic and clinical specificities observed in more than 50% of patients. Results. The patients mean age was 67.3 years. The mean age of manifestation of symptoms and confirming the diagnosis was 59 years. US was performed in all 189 patients, whereas uroflowmetry only in 169 (89%). The average prostate volume was 55.2 cm<sup>3</sup>, average Qmax value - 10.8 ml/s. The mean age of a patient, who was tested for prostate-specific antigen (PSA) for the first time was 59.25 years. 154 (81.48%) patients at the moment of examination took medication for BPH, 108 (57.14%) of them assessed therapy as effective, 41 (21.69%) - as moderately effective, 5 (2.65%) reported that they did not notice any positive effect of therapy. Conclusion. According to the results we have obtained, a typical patient with BPH is a non-working man aged 67 years, who previously did not undergo surgical treatment for BPH. The patient is aware of the necessity of PSA test. He is sufficiently informed about modern surgical methods of management of BPH. The profile we received is indicative of a high quality of ambulatory care and treatment of outpatients with BPH. At the same time, we have found a number of defects in follow-up of outpatients, the elimination of which will improve the quality of medical care and patients' satisfaction with the outcomes of treatment.